Cleared Dual Track

K141775 - SOFIA STREP A+ FIA

K141775 is the FDA 510(k) clearance for SOFIA STREP A+ FIA by Quidel Corporation. It is a Class 1 Microbiology device (product code GTY) cleared through the Dual Track 510(k) pathway after a 168-day FDA review.

K141775 · Quidel Corporation · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
168d
Days
Class 1
Risk

K141775 is an FDA 510(k) clearance for the SOFIA (R) STREP A+ FIA. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Quidel Corporation (San Diego, US). The FDA issued a Cleared decision on December 16, 2014 after a review of 168 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Quidel Corporation devices

Submission Details

510(k) Number K141775 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2014
Decision Date December 16, 2014
Days to Decision 168 days
Submission Type Dual Track
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d slower than avg
Panel avg: 102d · This submission: 168d
Pathway characteristics

Device Classification

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 28
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K141775.
Flowflex® Plus Strep A Rapid Test Cassette
K251697 · ACON Laboratories, Inc. · Nov 2025
Healgen Strep A Rapid Test Strip (Throat Swab)
K212623 · Healgen Scientific, LLC · Mar 2022
Sofia Strep A+ FIA, Sofia 2 Analyzer
K171976 · Quidel Corporation · Dec 2017
WONDFO RAPID STREP A TEST
K133343 · Guangzhou Wondfo Biotech Co., Ltd. · Jan 2014
SOFIA STREP A FIA
K123793 · Quidel Corporation · Jun 2013
BD VERITOR(TM) SYSTEM FOR RAPID DETECTION OF GROUP A STREP
K122718 · Becton, Dickinson and Company · Feb 2013